HIF1A and central nervous system cancer: The disruption of HIF-1α by the intratumoral injection of small-interfering RNA (siRNA) was reported to result in the regression of human glioma xenografts (16), and in the tumor stasis of human cervical cancer and colon cancer xenografts (17).